interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Motixafortide Acetate

Generic competition · all medicines · read 12 November 2026

Is there a generic of Motixafortide Acetate, and who makes it?

Motixafortide Acetate appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Motixafortide Acetate1 dosage-form group in the Orange Book
0generic makers listed
  1. Motixafortide Acetate appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Powder, Subcutaneous

Brand listed, no generic listed as marketed

Brand listed as marketed: Aphexda. No generic is listed as marketed.

20202025203020352040204501brand 2023data datePatent 12257285 listed to expire 29 December 2041Patent 12268725 listed to expire 29 December 2041Exclusivity NCE to 8 September 2028Exclusivity ODE-442 to 8 September 2030
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 8 September 2028Exclusivity NCE Aphexda
  • 8 September 2030Exclusivity ODE-442 Aphexda
  • 29 December 2041Patent 12257285 drug product
  • 29 December 2041Patent 12268725 drug product

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.